Osteonecrosis (ON) is a debilitating long-term complication of allogeneic BMT (allo-BMT), but may begin before allo-BMT in some children because of their primary disease treatment. Therefore, to estimate the prevalence and associated risk factors for ON before allo-BMT, we conducted a retrospective analysis of magnetic resonance (MR) studies of 118 children who underwent first allo-BMT at our institution between December 2000 and September 2007. Of the 118 consecutive patients, 107 (90.7%) underwent prospective MR studies irrespective of symptoms (69 males; median age at allo-BMT 12.9 years), and 11 underwent MR studies for symptoms. Among the 107 who had prospective imaging, 23 (21.5%) had ON; nearly 50% had at least 30% epiphyseal involvement. Knees were more frequently involved than were hips; severity of ON was greater in hips. ON prevalence before allo-BMT was 23.72% when all 118 patients were included in the denominator. Risk factor analysis, limited to MR studies performed irrespective of symptoms, revealed female gender (P ¼ 0.049) and age X10 years at the time of MR study (P ¼ 0.03) as significant risk factors, and primary diagnosis of lymphoid malignancies and aplastic anemia trended toward significance. ON before allo-BMT is a common occurrence in children.
Introduction
Osteonecrosis (ON) is a potentially persistent and debilitating complication after allogeneic BMT (allo-BMT). [1] [2] [3] [4] [5] [6] Incidences in pediatric populations range from 3.9 to 44.2%. [7] [8] [9] These lesions can progress and eventually lead to collapse of affected joints, [10] [11] [12] making joint replacement necessary while the individual is still a teenager or young adult. Joint replacement in teenagers and young adults is undesirable because these patients will typically require additional revisions and replacements as they age. 3, 12, 13 The prevalence of ON and its probable risk factors, such as acute or chronic GVHD requiring steroids, increasing age and a primary diagnosis of aplastic anemia or acute leukemia, have been documented in post-BMT settings in mixed populations. 1, 5, 6 However, the prevalence and risk factors for developing ON before BMT remain undefined. Children who undergo BMT have primary diseases that are often associated with the occurrence of ON either as a direct result of disease pathology (for example, in sickle-cell disease) 14, 15 or secondary to the high-dose chemotherapy or steroids used for treatment (for example, leukemias). [16] [17] [18] Because these children are exposed to bone-toxic factors even before undergoing BMT, it is possible that ON may develop before BMT in some cases.
Identifying the subset of children who will develop pretransplantation ON or who may be at risk of post transplantation ON progression will help in early recognition of this debilitating condition, which may allow intervention in stages preceding collapse when joint-preserving procedures are possible. 19 It will also allow suitable tailoring of medical management post-BMT and provide timely counseling of parents and patients. Early recognition will also help assess the true affect of BMT on the evolution of ON and allow development of interventions to ameliorate ON progression and maintain joint function. We therefore conducted a retrospective analysis of magnetic resonance (MR) images and medical records of 118 children who underwent first allo-BMT at St Jude Children's Research Hospital between December 2000 and September 2007 to estimate the prevalence of ON and to identify risk factors for its development before allo-BMT in this population.
Patients and methods

Study population
We conducted a retrospective review of medical records and MR images of children who underwent first allo-BMT for malignant or nonmalignant conditions at St Jude Children's Research Hospital between December 2000 and September 2007. Only patients for whom MR imaging results of hips, knees or both before the first allo-BMT were available were included in the reported cohort. This cohort was further divided into two groups: MR studies performed irrespective of symptoms (group 1) and MR studies performed for symptoms only (group 2). Since January 2002, patients undergoing evaluation for allo-BMT at St Jude Children's Research Hospital undergo a baseline protocol-driven MR of hips and knees before allo-BMT. Also included in group 1 were patients who had undergone MRs of hips, knees or both as a part of their primary disease follow-up assessment irrespective of symptoms. Typically, patients with ALL undergo MR studies after every reinduction therapy. Patients with AML undergo prospective MR studies of the femur to assess marrow response to therapy, and patients with sickle-cell disease undergo MR studies because of the recognized increased risk of ON in these patients. 14, 20 To avoid bias, risk factor analysis was restricted to group 1 patients only. Institutional review board approval was obtained for this study, and data were managed according to the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
Osteonecrosis
The presence of ON was determined using MR imaging. As a standard of care at our institution, patients being evaluated for ON undergo coronal noncontrast T 1 -weighted and short tau inversion recovery imaging of the hips and/or knees and sagittal fast low angle shot two-dimensional imaging of the articular surfaces. Imaging studies were performed with either a Siemens 1.5T Symphony or a Vision MR Unit (Siemens, Inc., Erlangen, Germany). The images were reviewed and interpreted by an experienced pediatric radiologist (SCK). As described previously, ON is defined as a geographic area of decreased signal on T1-weighted and increased signal on short tau inversion recovery.
12,21 ON locations were classified as epiphyseal, metaphyseal or diaphyseal. Because the extent of epiphyseal involvement is an important predictor of joint outcome, the extent of epiphyseal involvement was categorized as X30 or o30% of the weight-bearing volume. 12 Thus, hip joint involvement was coded according to the involvement of the capital femoral epiphysis, and knee joints were coded as involved if an ON lesion was present in either the distal femoral or the proximal tibial epiphysis. For patients who underwent multiple MR studies before transplantation, the examination demonstrating the most severe ON was the one used for analysis. The distribution of joint involvement is important for designing interventions to ameliorate ON. Therefore, the pattern of joint involvement was also studied.
Risk factors
Risk factor analysis was done only for the patients who had MR studies irrespective of symptoms (that is, group 1).
The following risk factors were studied to determine their associations with ON: gender, race, age at MR imaging (that is, o10 or X10 years), age at primary diagnosis, primary diagnosis, and body mass index (BMI) at the time of the MR study. BMI at the time of MR study was calculated only for patients 42 years, as per the criteria of the Centers for Disease Control and Prevention (CDC) (www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/ about_childrens_bmi.html). 22 Participants were categorized as healthy, underweight, overweight or obese as per the CDC criteria. 22 Malignant conditions were categorized as lymphoid (that is, ALL, non-Hodgkin's lymphoma and Hodgkin's disease) or non-lymphoid malignancies (that is, AML/myelodysplastic syndrome, CML, sarcoma and neuroblastoma). Also, because statistical power for eliciting the effect of individual treatment regimens was limited and individual cumulative doses of steroids received by each patient were not available, we categorized primary diagnoses on the basis of known contemporary treatment protocols to assess the potential effect of steroids. Diagnoses were grouped as follows: lymphoid malignancies and aplastic anemia or other conditions (that is, AML/myelodysplastic syndrome, CML, sarcoma, sicklecell disease, Duncan's syndrome, hemophagocytic lymphohistiocytosis and hyper-IgM syndrome).
Statistical analyses
Descriptive statistics were used to describe the study population by gender, race, age at MR study, age at allo-BMT, BMI at MR study and primary diagnosis. To assess the internal validity of our cohort, t-tests and w 2 statistics were used to compare the characteristics of group 1 participants to those of all other allo-BMT recipients treated during the same time.
ON prevalence rates were calculated for epiphyseal involvement of any of the four lower extremity joints as well as for hips and knees separately. The pattern of joint involvement was also examined by evaluating the number of lower extremity joints involved at the time point when the MR study showed the highest grade of ON.
Logistic regression models were used to examine the associations between potential risk factors and the development of ON in any of the four joints. Risk factors that were statistically significant in univariate analysis and those that were clinically significant were further examined in multiple-regression models. Data were analyzed using SAS (Version 9.13; SAS Institute, Inc., Cary, NC, USA). Statistical significance was set at the a-error level of 0.05.
Results
Demographic characteristics of the study population
Of the 344 consecutive patients who underwent first allo-BMT at St Jude Children's Research Hospital from December 2000 to September 2007, 226 were excluded from further analysis because they did not have a pre-allo-BMT MR study ( Figure 1 ). In all, 118 patients had preallo-BMT MR studies. Among these patients, 107 (90.7%) had MR studies irrespective of symptoms (group 1), and 11 (10.3%) patients had MR studies because of symptoms (group 2; Figure 1 ). All patients underwent treatment for their primary disease as per the institutional or cooperative group protocols. The demographic characteristics of group 1 are shown in Table 1 , and the demographic and clinical characteristics of group 2 are in Table 2 . The time from peak ON to allo-BMT for the two groups is in Table 3 .
The median age of group 1 at the time of MR study was 12.9 years (range 0.5-21.1), and the median time from diagnosis to allo-BMT was 20.2 months (range 2.4-205.9; Table 1 ). In all, 89 patients (83.2%) had malignant diseases and 18 (16.8%) had nonmalignant diseases (Tables 4 and  5) . Among the 107 patients examined prospectively, 76 (71.03%) had one, 9 (8.41%) had two, 9 (8.41%) had three and 13 (12.15%) had more than three MR studies. Hip MR studies were available for 103 patients (96.26%), and knee MR studies were available for 84 patients (78.50%). Additionally, the distributions of gender, diagnoses and BMI did not differ between group 1 and the remaining population, although the distribution of age at transplant and race did differ between these groups (Table 4) .
Prevalence, severity and extent of ON When all four joints were considered, prevalence of ON for groups 1 and 2 collectively was 28 of 118 (23.72%). In those patients who had MR studies irrespective of symptoms, prevalence was 23 of 107 (21.5%) when all four joints were considered; 16 of 84 (23.5%) had knee involvement, and 12 of 103 (11.7%) had hip involvement (Table 6 ). Of 12 patients with hip ON, 8 (66.7%) had X30% of epiphyseal involvement, whereas only 3 (18.8%) of 16 patients with knee ON had X30% of epiphyseal involvement (Table 6 ).
Pattern of joint involvement
The pattern of joint involvement in patients with ON in group 1 is shown in Table 7 . Of the 23 patients with ON, 12 (52.2%) had more than one joint involved ( Table 7) . The most frequent pattern of multiple joint involvement was that of bilateral knees.
Risk factors
An age of X10 years at MR imaging and female gender were associated with greater odds of developing ON (odds ratio 4.50, 95% confidence interval 1.16-17.17; and odds ratio 2.70, 95% confidence interval 1.00-7.27, respectively; Table 8 ). There was also a trend toward significance for primary diagnosis of lymphoid malignancies or aplastic anemia (odds ratio 2.72, confidence interval 0.99-7.48) after adjusting for age and gender. The other risk factors studied were not associated with an increased risk of developing ON (Table 8) .
Discussion
One striking observation in our cohort is that approximately half the patients with ON had at least 30% epiphyseal involvement, indicating the existence of significant joint morbidity before allo-BMT. Although regression of small lesions has been reported, 11, 23 large lesions have consistently been associated with high rates of progression and joint collapse. For example, Karimova et al. 12 found that lesions occupying X30% of the femoral head volume were associated with an increased risk of joint collapse or a need for arthroplasty in 48% of patients. In our study, adolescent females emerged as a conspicuous risk group for developing ON. Studies in ALL and post allo-BMT patients have identified treatment with intensive chemotherapy and age of X10 years as the major risk factors for the development of ON in children. 1, 2, 6, 9, 16, 18 However, whether or not an association between gender and development of ON exists is unclear. 1, 5, 16, 18 Theoretically, an increased risk of ON in females may be related to earlier onset of puberty with earlier physeal closure. 24, 25 Mature bone may be more vulnerable to rises in intraosseous pressure than immature bone, 26 leading to ischemia and ON. Because we did not assess pubertal stage, bone age or sex hormone levels, we could not analyze the potential association between puberty and ON. Also, as suggested by Schulte et al., 5 sexual dimorphism in the morphogenesis potential of osteoblasts may need further exploration to clarify whether or not there exists an association between gender and the development of ON.
Our data indicate a potential association between primary diagnoses of lymphoid malignancies or aplastic anemia and the development of ON. These data are supported by earlier studies that indicate acute leukemias and aplastic anemia as risk factors for post-BMT ON. 1 ON has recently been reported as a morbid skeletal complication among children being treated for ALL with incidences up to 38%. 16, 17 Park et al. 27 reported ON in five children with aplastic anemia before any therapy.
Although cumulative steroid dose information was not available for the children in our cohort, our trend toward significance among those with lymphoid malignancies or aplastic anemia indicates that steroids are a potential risk factor for ON. Previous literature indicates that ON among children with ALL is associated with higher doses of steroids and other chemotherapeutic agents. [16] [17] [18] 28, 29 Similarly, ON in patients with aplastic anemia is associated with antilymphocyte globulin followed by high-dose methylprednisolone. 30 However, because information was not available on the cumulative doses of steroids in our cohort, we could not distinguish the effect of disease pathophysiology, if any, from treatment dose-related effects for these children. Osteonecrosis in children before allo-BMT S Sharma et al ON observed in our patients with other diagnoses such as sickle-cell disease, CML, AML and sarcomas is well supported in literature. [31] [32] [33] [34] [35] [36] [37] Reported risk factors for ON include steroids, vaso-oclusive episodes, chemotherapeutic agents such as MTX, asparaginase and CY and diseaserelated disturbances in coagulation mechanisms. A direct comparison between prevalence rates in this study and those of previous studies is difficult because of the smaller number of patients in individual groups and the diverse diagnostic criteria used. Furthermore, we found no significant relationship between ON and race or BMI, in contrast to reports indicating that white patients with ALL have a higher risk than do patients of other races. 18, 38 Consistent with previous reports, 1,2,16,17,27,39 we found multi-articular involvement in our cohort. However, whereas previous studies using symptom-driven imaging to document ON indicated an increased frequency of hip involvement, 1,4,6,28,29 our study, using prospective imaging, indicated knee involvement to be more frequent than hip involvement. 7, 16 One possible reason for knee involvement to be underdiagnosed in symptomatic patients is that knee pain may be interpreted as referred pain from concurrent ipsilateral hip involvement.
The results of our study should not be interpreted without taking into account its potential limitations. First, this cohort was older than the overall pre-allo-BMT population at St Jude Children's Research Hospital. Table 4 Characteristics of patients who had pre-allo-BMT prospective MR studies who were included in risk factor analysis (that is, group 1; N ¼ 107) vs all others who underwent allo-BMT during the study period (N ¼ 226+ 11 (group 2))
Characteristics
Patients with prospective pre-BMT MR studies (group1) (n (%))
All others who underwent allo-BMT during the study period (n (%)) a Some patients did not undergo MR studies of both hips and both knees before allo-BMT; therefore, the actual number of positive results in any joint might be higher than that presented. Osteonecrosis in children before allo-BMT S Sharma et al Therefore, the prevalence calculated for our patients could be an overestimation, as older age has been consistently related to a higher incidence of ON. Second, we could not determine the effect of individual treatment regimens and disease pathophysiology on the development of ON. Therefore, because of the diversity of therapy for various diagnoses, we cannot generalize our findings to children undergoing allo-BMT at other centers. Despite these limitations, our study provides insight into a skeletal toxicity that may develop before allo-BMT and could possibly exacerbate during the transplantation period when the patient is subjected to additional bone-toxic therapy.
P-value
On the basis of this single-institution retrospective study of prospectively acquired MR studies in a modestly large pediatric population, we conclude that ON before allo-BMT is a common occurrence in children. A high index of suspicion, and, if possible, prospective screening before allo-BMT of adolescent females with lymphoid malignancies or aplastic anemia may help identify this debilitating disease at pre-collapse stages when joint-preserving interventions are feasible in this young population. This complication also needs to be considered while developing preparatory and follow-up monitoring protocols for these patients and while counseling parents and children. Future studies are required to elucidate the physiological basis of the effect of gender on the evolution of ON as well as to develop appropriate interventions to prevent or ameliorate ON.
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